Haznedaroglu, Ibrahim. “MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)”. Mediterranean Journal of Hematology and Infectious Diseases 6, no. 1 (December 31, 2013): e2014009. Accessed August 20, 2019. http://www.mjhid.org/index.php/mjhid/article/view/2014.009.